Publikationen, an denen er mitarbeitet Beatriz Díaz Molina (21)

2024

  1. IL-10 indirectly modulates functional activity of CD4+CD28null T-lymphocytes through LFA-3 and HLA class II inhibition

    Immunology, Vol. 173, Núm. 2, pp. 296-309

2023

  1. Opportunistic Genetic Screening for Familial Hypercholesterolemia in Heart Transplant Patients

    Journal of Clinical Medicine, Vol. 12, Núm. 3

2021

  1. CMV Infection Is Directly Related to the Inflammatory Status in Chronic Heart Failure Patients

    Frontiers in Immunology, Vol. 12

2019

  1. Cambios morfológicos anulares tras reparación mitral transcatéter: repercusión clínica y relevancia de la etiología

    REC: Interventional Cardiology, Vol. 1, Núm. 1, pp. 34-40

  2. Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and risk for early-onset coronary artery disease

    Immunology Letters, Vol. 208, pp. 39-43

2018

  1. Early Everolimus Initiation Fails to Counteract the Cytotoxic Response Mediated by CD8+ T and NK Cells in Heart Transplant Patients

    Frontiers in immunology, Vol. 9, pp. 2181

  2. Genetic variation at the long noncoding RNA H19 gene is associated with the risk of hypertrophic cardiomyopathy

    Epigenomics, Vol. 10, Núm. 7, pp. 865-873

  3. More intensive CMV-infection in chronic heart failure patients contributes to higher T-lymphocyte differentiation degree

    Clinical Immunology, Vol. 192, pp. 20-29

  4. Valve in valve" through femoral approach to allow the later implantation of long-term left ventricle assist device: A case report

    Journal of Thoracic Disease, Vol. 10, Núm. 6, pp. E447-E449

2017

  1. Screening of the Filamin C Gene in a Large Cohort of Hypertrophic Cardiomyopathy Patients

    Circulation: Cardiovascular Genetics, Vol. 10, Núm. 2

2016

  1. Left ventricle non-compaction: The still misdiagnosed cardiomyopathy

    International Journal of Cardiology, Vol. 223, pp. 420-421

  2. Quality of Life According to Urgency Status in De Novo Heart Transplant Recipients

    Transplantation Proceedings, Vol. 48, Núm. 9, pp. 3024-3026

2015

  1. Effect of early conversion to everolimus together with prophylaxis with valganciclovir in the prevention of cytomegalovirus infection in heart transplant recipients

    Transplantation Proceedings

2014

  1. Immunosenescence and inflammation characterize chronic heart failure patients with more advanced disease

    International Journal of Cardiology, Vol. 174, Núm. 3, pp. 590-599

2012

  1. Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with Tacrolimus

    Molecular Genetics and Metabolism, Vol. 105, Núm. 3, pp. 525-527

2011

  1. Mitochondrial DNA and TFAM gene variation in early-onset myocardial infarction: Evidence for an association to haplogroup H

    Mitochondrion, Vol. 11, Núm. 1, pp. 176-181

2007

  1. Intimal dehiscence during endovascular treatment of thoracic aortic dissection

    International Journal of Cardiology, Vol. 114, Núm. 1

  2. The relationship of anti-MICA antibodies and MICA expression with heart allograft rejection

    American Journal of Transplantation, Vol. 7, Núm. 7, pp. 1842-1848

2006

  1. An incidental finding during cardiac catheterization

    International Journal of Cardiology, Vol. 106, Núm. 1, pp. 137-138

  2. Post-transplant soluble MICA and MICA antibodies predict subsequent heart graft outcome

    Transplant Immunology, Vol. 17, Núm. 1, pp. 43-46